| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825890 | Current Opinion in Pharmacology | 2016 | 5 Pages |
Abstract
The current review will focus on emerging treatments of osteoporosis with the potential of enhanced anabolic effects (romosozumab and abaloparatide) or uncoupling of resorption and formation (odanacatib and romosozumab) as well as the effect of combination therapy.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Torben Harsløf, Bente L Langdahl,